Skip to main content
. 2024 Feb 29;16(3):345. doi: 10.3390/pharmaceutics16030345
CAF Cancer-associated Fibroblast
CT Computerized Tomography
DPP Dipeptidyl Peptidase
FAP Fibroblast Activation Protein
FAPI FAP Inhibitor
FDA Food and Drug Administration
IC50 Half Maximal Inhibitory Concentration
ID/g Injected Dose/Gram
MAb Monoclonal Antibody
mCRPC Metastatic Castration-resistant Prostate Cancer
MIP Maximum Intensity Projection
NIR Near-infrared
PET Positron Emission Tomography
PK Pharmacokinetic
SPECT Single Photon Emission Computed Tomography
TME Tumor Microenvironment
T/K Tumor-to-kidney Ratio